Jeremy Edson

Dec 8, 2023 | pharmaceuticalonline.com | Kate Coleman |David Nobile |Matt Hicks |Jeremy Edson

As we approach the end of 2023, and pharma/biotech companies finesse their road maps for 2024, this article assesses the six priorities vying for attention. Why There Is No Such Thing As An ISO Class 5 WipeLearn why it is not possible to definitively categorize or certify wipes for a specific class of cleanroom environment. Your Capital Equipment Project Is Cancelled: Now What?

Oct 5, 2023 | pharmaceuticalonline.com | Paul Cummings |Travis McCready |Erik Adams |Jeremy Edson

Choosing the right CDMO is a complex and difficult task and, given the regulatory framework within which the industry operates, it is essential that companies seeking a CDMO get the right partner. Let's look at what you should include in RFPs and other key considerations.